Skip to main content
DNA Labs India

COL2A1 Gene Spondyloperipheral dysplasia NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

COL2A1 Gene Spondyloperipheral dysplasia NGS Genetic Test

Short Name: COL2A1 SPD NGS Test

Also known as: COL2A1 Gene Test, Spondyloperipheral Dysplasia Genetic Test, COL2A1 NGS Test

COL2A1 Gene Spondyloperipheral dysplasia NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.

NGSPediatric, Adult🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify pathogenic mutations in the COL2A1 gene that cause Spondyloperipheral dysplasia. It aids in confirming clinical diagnosis, enabling early intervention, and providing accurate genetic counseling for affected families.

Test Code
5941
CPT Code
81408
ICD Code
Q77.8
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting required. Provide clinical history and pedigree chart. Genetic counseling session is recommended.

Method: Venipuncture or FTA card spot

Step 2

Laboratory Analysis

Blood sample will be collected by a trained phlebotomist. For FTA card, a drop of blood is applied.

Step 3

Report Delivery

No special precautions. The sample will be transported to the lab for analysis.

Timeline: 3 to 4 weeks

Patient Instructions

1
Before the Test:No special preparation required. However, a genetic counseling session is recommended to discuss the implications of the test.
2
During the Test:A blood sample will be drawn, or a FTA card spot will be collected. The procedure is quick and minimally invasive.
3
After the Test:You can resume normal activities immediately. Results will be available in 3-4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to identify pathogenic mutations in the COL2A1 gene that cause Spondyloperipheral dysplasia. It aids in confirming clinical diagnosis, enabling early intervention, and providing accurate genetic counseling for affected families.

How to Prepare

  • Ensure the sample is labeled correctly with patient details.
  • For blood, use EDTA tube and mix gently.
  • For FTA card, allow the spot to dry completely before packaging.
  • Maintain sample at ambient temperature during transport.

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing for COL2A1 mutations is essential for confirming SPD diagnosis and enabling accurate family counseling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 FTA spot
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or FTA card spot

Sample Stability

Blood (EDTA)
Extracted DNA
FTA card
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Improperly labeled sample
  • Sample exposed to extreme temperatures

Understanding Your Results

The genetic test report will indicate whether a pathogenic variant in the COL2A1 gene was identified. If a variant is found, its clinical significance will be classified based on ACMG guidelines.
📊

Pathogenic variant detected

Confirms diagnosis of Spondyloperipheral dysplasia. Genetic counseling recommended.

📊

Likely pathogenic variant detected

Highly suggestive of SPD; further testing may be needed for confirmation.

📊

Variant of uncertain significance (VUS)

Cannot determine clinical significance; additional family studies may help.

📊

No pathogenic variant detected

Does not rule out SPD; other genetic causes may be considered.

⚠️ When to Consult a Doctor:

Consult a geneticist or orthopedic specialist if you or your child have symptoms suggestive of SPD, or if you have a family history of COL2A1-related conditions.

Limitations

  • This test detects mutations in the COL2A1 gene only; other genes may be involved in similar phenotypes.
  • NGS may not detect large deletions/duplications or deep intronic variants.
  • Variant interpretation may require additional familial testing.
  • Results should be interpreted in the context of clinical findings.

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of genetic results
  • Potential for uncertain results

Interfering Factors

  • Contaminated or degraded DNA sample
  • Incomplete clinical information
  • Presence of maternal cell contamination (if prenatal)
  • Rare variants of uncertain significance

Compare With Similar Tests

TestCOL2A1 Gene Spondyloperipheral dysplasia NGS Genetic TestCOL2A1 Gene Sequencing (Sanger)Skeletal Dysplasia Panel (NGS)Whole Exome Sequencing
ComparisonCOL2A1 Gene Spondyloperipheral dysplasia NGS Genetic TestTargeted single-gene sequencing; lower throughput, may miss large deletions.Analyzes multiple genes including COL2A1; broader coverage but higher cost.Comprehensive analysis of all exons; most extensive but expensive.

Frequently Asked Questions

What is Spondyloperipheral dysplasia?
Spondyloperipheral dysplasia is a rare genetic disorder affecting the skeletal system, caused by mutations in the COL2A1 gene. It leads to short stature, spinal curvature, and limb malformations.
How is the COL2A1 gene test performed?
The test uses next-generation sequencing (NGS) to analyze the COL2A1 gene from a blood sample or extracted DNA. It detects mutations that may cause SPD.
What is the cost of the test?
The cost is INR 20,000, which includes genetic counseling and the NGS analysis. Home sample collection is free.
Do I need to fast before the test?
No, fasting is not required for this genetic test.
What sample is needed?
Blood (2-3 ml in EDTA tube) or extracted DNA or one drop of blood on an FTA card.
How long does it take to get results?
Results are typically available in 3 to 4 weeks.
Can this test detect carriers of the mutation?
Yes, the test can identify carriers of COL2A1 mutations, which is useful for family planning.
Is genetic counseling included?
Yes, a genetic counseling session is included to draw a pedigree chart and discuss the implications.
Is home sample collection available?
Yes, we offer free home sample collection in many cities across India.
What does a positive result mean?
A positive result indicates a pathogenic variant in COL2A1, confirming the diagnosis of SPD. Genetic counseling is recommended.
Are there any risks associated with the test?
The test is safe with minimal risks like bruising at the blood draw site. No significant physical risks.
Can this test be done for prenatal diagnosis?
Yes, with appropriate counseling and sample types (e.g., amniotic fluid), it can be used for prenatal diagnosis.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.